Bank Of America Corp /De/ - Sep 30, 2025 Form 3 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
10%+ Owner
Signature
/s/ Andres Ortiz, Authorized Signatory for Bank of America Corporation
Stock symbol
APVO
Transactions as of
Sep 30, 2025
Transactions value $
$0
Form type
3
Date filed
10/3/2025, 01:59 PM
Previous filing
Sep 29, 2025
Next filing
Oct 3, 2025
SEC
View on sec.gov

Reporting Owners (3)

Name Relationship Address Signature Signature date CIK
BANK OF AMERICA CORP /DE/ 10%+ Owner BANK OF AMERICA CORPORATE CENTER, 100 N TRYON ST, CHARLOTTE /s/ Andres Ortiz, Authorized Signatory for Bank of America Corporation 2025-10-03 0000070858
BANK OF AMERICA NA 10%+ Owner 100 NORTH TRYON STREET, CHARLOTTE /s/ Andres Ortiz, Authorized Signatory for Bank of America N.A. 2025-10-03 0001102113
BOFA SECURITIES, INC. 10%+ Owner 150 N COLLEGE ST, NC1-028-28-04, CHARLOTTE /s/ Andres Ortiz, Authorized Signatory for BofA Securities, Inc. 2025-10-03 0001675365

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APVO Common Stock 27 Sep 30, 2025 See Footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The 27 common stock shares ("Shares") reported as acquired in Table I represent Shares of APTEVO THERAPEUTICS INC.("the Issuer") beneficially owned by Bank of America N.A. ("BANA"), and BofA Securities, Inc. ("BOFAS"). BANA and BOFAS are wholly owned subsidiaries of Bank of America Corporation ("Bank of America"). The Reporting Owners may be deemed to have temporarily held voting and dispositive power over additional shares as a result of short-term stock borrowings.
F2 This statement is jointly filed by Bank of America, BANA and BOFAS. Bank of America holds an indirect interest in the securities listed in Table I ("the Securities") by virtue of its indirect ownership of its subsidiaries, BANA and BOFAS.
F3 Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) of the US Securities Exchange Act of 1934 or any other purpose, (i) acting (or has agreed or is agreeing to act together with any other person) as a partnership, limited partnership, syndicate, or other group for the purpose of acquiring, holding or disposing of securities of the Issuer or otherwise with respect to the Issuer or any securities of the Issuer of (ii) a member of any group with respect to the Issuer or any securities of the Issuer.